Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe history now includes a new revision entry (v3.3.3) and removes the older entries for HHS Vulnerability Disclosure and revision v3.3.2.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, and the prior revision v3.3.1 was removed.SummaryDifference0.1%

- Check39 days agoChange DetectedThe Record History now shows a new revision entry v3.3.1 and removes v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the government funding notice about NIH operational status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedThe latest version adds a Recruitment Status section to the record view, making current enrollment status visible alongside other study details. This enhances visibility of the trial's progress within the page.SummaryDifference0.1%

- Check90 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.